A Zink

Summary

Affiliation: German Rheumatism Research Centre
Country: Germany

Publications

  1. doi request reprint [Healthcare research in rheumatology. Current state]
    A Zink
    Programmbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, 10117, Berlin, Deutschland
    Z Rheumatol 73:115-22. 2014
  2. pmc Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register
    Joachim Listing
    German Rheumatism Research Centre, Berlin, Germany
    Arthritis Res Ther 8:R66. 2006
  3. pmc Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
    Anja Strangfeld
    German Rheumatism Research Centre Berlin, a Leibniz Institute, Chariteplatz 1, 10117 Berlin, Germany
    Arthritis Res Ther 12:R5. 2010
  4. ncbi request reprint [The National Database of the Regional Collaborative Rheumatic Centers as a tool for clinical epidemiology and quality assessment in rheumatology]
    Angela Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin
    Z Arztl Fortbild Qualitatssich 97:399-405. 2003
  5. ncbi request reprint Longterm studies in rheumatoid arthritis--the German experience
    Angela Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin
    J Rheumatol Suppl 69:22-6. 2004
  6. ncbi request reprint Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers
    A Zink
    German Rheumatism Research Center, Department of Internal Medicine, Klinikum Benjamin Franklin, Berlin, Free University
    J Rheumatol 27:613-22. 2000
  7. ncbi request reprint [Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologics Register RABBIT]
    A Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin
    Z Rheumatol 65:441-6. 2006
  8. ncbi request reprint [National database of German arthritis centers. Tool for health services research]
    A Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Berlin
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:526-32. 2004
  9. ncbi request reprint Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres
    A Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Lupus 13:529-36. 2004
  10. ncbi request reprint [The National Database of the German Arthritis Centres--a 12 year balance]
    A Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin
    Z Rheumatol 65:144, 146-51. 2006

Detail Information

Publications65

  1. doi request reprint [Healthcare research in rheumatology. Current state]
    A Zink
    Programmbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, 10117, Berlin, Deutschland
    Z Rheumatol 73:115-22. 2014
    ..Health services research impressively shows the advances in rheumatological care. Further improvements at the population level are limited by the low numbers of rheumatologists in outpatient care. ..
  2. pmc Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register
    Joachim Listing
    German Rheumatism Research Centre, Berlin, Germany
    Arthritis Res Ther 8:R66. 2006
    ..However, temporary or even sustained remission remain ambitious aims, which are achieved in a minority of patients only...
  3. pmc Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
    Anja Strangfeld
    German Rheumatism Research Centre Berlin, a Leibniz Institute, Chariteplatz 1, 10117 Berlin, Germany
    Arthritis Res Ther 12:R5. 2010
    ....
  4. ncbi request reprint [The National Database of the Regional Collaborative Rheumatic Centers as a tool for clinical epidemiology and quality assessment in rheumatology]
    Angela Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin
    Z Arztl Fortbild Qualitatssich 97:399-405. 2003
    ..Specific deficits have been identified concerning the provision of occupational therapy services and patient education...
  5. ncbi request reprint Longterm studies in rheumatoid arthritis--the German experience
    Angela Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin
    J Rheumatol Suppl 69:22-6. 2004
    ..It has, however, the important limitation that no specific followup procedure is applied. Therefore, longitudinal data exist only for patients in continuing rheumatological care...
  6. ncbi request reprint Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers
    A Zink
    German Rheumatism Research Center, Department of Internal Medicine, Klinikum Benjamin Franklin, Berlin, Free University
    J Rheumatol 27:613-22. 2000
    ....
  7. ncbi request reprint [Dose adjustment in patients treated with infliximab in routine rheumatologic care in Germany. Results from the Biologics Register RABBIT]
    A Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin
    Z Rheumatol 65:441-6. 2006
    ..Using data from the German Biologics Register RABBIT we investigated: (1) how dosage of INF develops during the first year of treatment in routine care, and (2) how dosage translates into clinical effectiveness...
  8. ncbi request reprint [National database of German arthritis centers. Tool for health services research]
    A Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Berlin
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:526-32. 2004
    ..Selected results concerning the health care situation in specialized and nonspecialized care, practice variations in rheumatology, and the burden of illness in various diseases are reported...
  9. ncbi request reprint Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres
    A Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Lupus 13:529-36. 2004
    ..The great disparity in treatment intensity between rheumatologists and nonrheumatologists shows that the involvement of a specialist is needed equally in both diseases...
  10. ncbi request reprint [The National Database of the German Arthritis Centres--a 12 year balance]
    A Zink
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin
    Z Rheumatol 65:144, 146-51. 2006
    ..Selected results on the health care situation, practice variation in rheumatology and the burden of illness in various diseases are reported...
  11. pmc Treatment continuation in patients receiving biological agents or conventional DMARD therapy
    A Zink
    German Rheumatism Research Centre, Berlin, Germany
    Ann Rheum Dis 64:1274-9. 2005
    ....
  12. ncbi request reprint Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials
    Angela Zink
    German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany
    Arthritis Rheum 54:3399-407. 2006
    ....
  13. ncbi request reprint [Vaccination of children and adults with autoimmune diseases]
    A Zink
    Deutsches Rheuma Forschungszentrum Berlin und Rheumatologie, Charite Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin
    Z Rheumatol 66:101. 2007
  14. pmc The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients
    A Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Ann Rheum Dis 60:199-206. 2001
    ..To describe the aims, principles, and content of the German rheumatological database and to present data on patient mix and healthcare provision for the year 1998...
  15. pmc The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis
    A Zink
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Ann Rheum Dis 60:207-13. 2001
    ..To describe current treatment of patients with rheumatoid arthritis (RA) in German rheumatology...
  16. ncbi request reprint [How closely does rheumatology treatment follow the guidelines?: ambition and reality]
    A Zink
    Deutsches Rheuma ForschungsZentrum Berlin, Leibniz Institut, Forschungsbereich Epidemiologie, Chariteplatz 1, 10117, Berlin, Deutschland
    Z Rheumatol 69:318-26. 2010
    ..Low-dose glucocorticoids are the standard of care; of patients in rheumatological care, 88% received dosages up to 7.5 mg/d and 74% of up to 5 mg/d...
  17. ncbi request reprint Practice variation in the treatment of rheumatoid arthritis among German rheumatologists
    A Zink
    Epidemiology Unit, German Rheumatism Research Center, Berlin
    J Rheumatol 28:2201-8. 2001
    ..To describe practice variation in the treatment of rheumatoid arthritis (RA) among German rheumatologists with regard to drug and non-drug therapy...
  18. ncbi request reprint [National database documentation for collecting, controlling and quality assurance of new therapies in rheumatoid arthritis]
    A Zink
    Deutsches Rheuma Forschungszentrum Berlin Schumannstr 21 22, 10177 Berlin, Germany
    Z Rheumatol 60:469-72. 2001
    ..The usage and spread of new drugs and treatment principles is regularly observed. Discussion about practice variations in treatment contributes to the internal quality assessment in the participating arthritis centres...
  19. ncbi request reprint [Research in patient care in the rheumatology specialty network--what is the benefit for improving patient care?]
    A Zink
    Deutsches Rheuma Forschungszentrum Berlin Forschungsbereich Epidemiologie Schumannstr 21 22 1077 Berlin, Germany
    Z Rheumatol 61:3-12. 2002
    ..The involvement of rheumatology into new concepts of care offers the chance to show the effectiveness of rheumatologic care and to enhance existing forms of cooperation...
  20. doi request reprint European biologicals registers: methodology, selected results and perspectives
    A Zink
    German Rheumatism Research Centre, Epidemiology Unit, Chariteplatz 1, 10117 Berlin, Germany
    Ann Rheum Dis 68:1240-6. 2009
    ....
  21. ncbi request reprint Ethical and legal constraints on data sharing between countries in multinational epidemiological studies in Europe report from a joint workshop of the European League Against Rheumatism standing committee on epidemiology with the "AutoCure" project
    A Zink
    Epidemiology Unit, German Rheumatism Research Centre, Chariteplatz 1, 10117 Berlin, Germany
    Ann Rheum Dis 67:1041-3. 2008
    ..The aim of the workshop was to share current knowledge on the above-mentioned topics, to identify areas for joint action and to enhance the likelihood of success for the new funding programmes...
  22. ncbi request reprint Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis
    Angela Zink
    German Rheumatism Research Centre, Berlin, Germany
    J Rheumatol 33:86-90. 2006
    ..To compare quality of life and treatment among patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and ankylosing spondylitis (AS) treated by German rheumatologists...
  23. pmc Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany
    D Huscher
    German Rheumatism Research Centre, Berlin, Germany
    Ann Rheum Dis 65:1175-83. 2006
    ....
  24. ncbi request reprint [Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany]
    J Brandt
    Klinikum Benjamin Franklin, Medizinische Klinik I, Rheumatologie, Hindenburgdamm 30, 12200 Berlin, Germany
    Z Rheumatol 62:264-73. 2003
    ..The purpose of this study was the validation of a German translation of the Bath Ankylosing Spondylitis Index (BASDAI)...
  25. doi request reprint Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide
    A Strangfeld
    German Rheumatism Research Centre, Epidemiology Unit, 10117 Berlin, Germany
    Ann Rheum Dis 68:1856-62. 2009
    ....
  26. pmc Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis
    J Listing
    Deutsches Rheuma ForschungsZentrum, Berlin, Germany
    Ann Rheum Dis 63:1670-2. 2004
    ..To analyse the impact of infliximab treatment on the number of hospital inpatient days and days of sick leave in patients with active ankylosing spondylitis (AS)...
  27. ncbi request reprint Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial
    J Braun
    Benjamin Franklin Hospital, Free University, Berlin, Germany
    Arthritis Rheum 48:2224-33. 2003
    ..The purpose of this study was to evaluate the efficacy and safety of infliximab treatment of AS for a 1-year period...
  28. ncbi request reprint The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database
    K Minden
    German Rheumatism Research Centre, Berlin, Germany
    Clin Exp Rheumatol 27:863-9. 2009
    ..To estimate the cost of juvenile idiopathic arthritis (JIA) and to evaluate the influence of specific disease characteristics on the various costs domains...
  29. doi request reprint [Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist]
    G Westhoff
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, Berlin, Germany
    Z Rheumatol 69:910-8. 2010
    ..However, these efforts can only succeed with a significant increase in the number of rheumatologists, while ensuring a firm economic basis...
  30. pmc Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
    A Strangfeld
    Correspondence to Dr A Strangfeld, Programmbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, ein Leibniz Institut, Chariteplatz 1, 10117 Berlin, Germany
    Ann Rheum Dis 70:1914-20. 2011
    ..To examine the risk of serious infection conveyed by tumour necrosis factor α (TNFα) inhibitors in the treatment of rheumatoid arthritis (RA)...
  31. ncbi request reprint [Out-of-pocket medical spending for care in patients with recent onset rheumatoid arthritis]
    G Westhoff
    Deutsches Rheuma ForschungsZentrum Berlin, Forschungsbereich Epidemiologie, Schumannstrasse 21 22, 10117 Berlin, Germany
    Z Rheumatol 63:414-24. 2004
    ..As policymakers discuss cost sharing and design of benefit packages to contain health spending, it is important to consider the expenditures that persons with chronic conditions like rheumatoid arthritis already have...
  32. pmc Ankylosing spondylitis: an overview
    J Sieper
    Department of Gastroenterology and Rheumatology, UKBF, Free University, Hindenburgdamm 30, 12200 Berlin, Germany
    Ann Rheum Dis 61:iii8-18. 2002
    ..Emerging biological therapies target the inflammatory processes underlying AS, and thus, may favourably alter the disease process, in addition to providing symptom relief...
  33. ncbi request reprint Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis
    G Westhoff
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Rheumatology (Oxford) 47:980-4. 2008
    ..To describe the association between morning stiffness (MS) and early retirement in patients with early RA...
  34. doi request reprint [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis]
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, ein Institut der Leibnizgemeinschaft, Programmbereich Epidemiologie, Chariteplatz 1, 10117 Berlin
    Z Rheumatol 72:339-46. 2013
    ..Data from BiKeR and JuMBO contribute to the risk-benefit assessment of biologic drugs which have been implemented in the routine treatment of JIA...
  35. ncbi request reprint [The importance of patient perspective in drug surveillance systems]
    L Gäwert
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, 10117, Berlin
    Z Rheumatol 69:795-802. 2010
    ..using data from the German biologics register RABBIT we investigated which gain in information can be achieved by integrating patient-reported adverse drug reactions (ADRs) into drug surveillance systems...
  36. doi request reprint Dose-related patterns of glucocorticoid-induced side effects
    D Huscher
    German Rheumatism Research Centre Berlin, Epidemiology Unit, Berlin, Germany
    Ann Rheum Dis 68:1119-24. 2009
    ..To identify patterns of self-reported health problems relating to dose and duration of glucocorticoid intake in unselected patients with rheumatoid arthritis from routine practice...
  37. ncbi request reprint [Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany]
    K Thiele
    Deutsches Rheuma ForschungsZentrum Berlin, Forschungsbereich Epidemiologie, 10117 Berlin, Germany
    Z Rheumatol 64:149-54. 2005
    ..The data emphasize the high importance of GCs in modern rheumatology...
  38. doi request reprint Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group
    G Westhoff
    Epidemiology Unit, German Rheumatism Research Centre Berlin, Chariteplatz 1, 10117 Berlin, Germany
    Rheumatology (Oxford) 47:849-54. 2008
    ..To investigate the influence of smoking on disease activity, drug need and radiographic joint damage in RF-positive and -negative patients with early RA...
  39. ncbi request reprint [Epidemiology of primary Sjörgren's syndrome]
    G Westhoff
    Forschungsbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, Chariteplatz 1, 10117 Berlin
    Z Rheumatol 69:41-9. 2010
    ..4% of the adult population which, at present, suffers from considerable immunopathologic sicca symptoms...
  40. pmc Atopic disorders in ankylosing spondylitis and rheumatoid arthritis
    M Rudwaleit
    Rheumatology, University Hospital Benjamin Franklin, Berlin, Germany
    Ann Rheum Dis 61:968-74. 2002
    ..The prevalence of atopic disorders in ankylosing spondylitis (AS) is unknown. AS and rheumatoid arthritis (RA) exhibit divergent T helper (Th) cell cytokine patterns...
  41. ncbi request reprint Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
    J Braun
    Department of Rheumatology, Benjamin Franklin Hospital, Free University of Berlin, Berlin, Germany
    Lancet 359:1187-93. 2002
    ..BACKGROUND Treatment options for patients with ankylosing spondylitis are few. We aimed to assess the effectiveness of infliximab, an antibody to tumour necrosis factor (TNF)-alpha, in treatment of such patients...
  42. ncbi request reprint [Basic treatment of early rheumatoid arthritis. Abstaining from rheumatological care and preferring alternative medicine increase the risk of undertreatment]
    G Westhoff
    Forschungsbereich Rheumatologie, Deutsches Rheuma Forschungszentrum Berlin DRFZ, Chariteplatz 1, 10117 Berlin
    Z Rheumatol 66:121-4, 126-8. 2007
    ..The positive influence of patient education on DMARD continuation emphasizes its importance...
  43. ncbi request reprint [Transition clinic--it is not always a simple segue in rheumatology for adults]
    K Minden
    HELIOS Kliniken, Klinikum Berlin Buch, II Klinik für Kinderheilkunde und Jugendmedizin und Deutsches Rheumaforschungszentrum Berlin, Forschungsbereich Epidemiologie, Schumannstr 21 22, 10117 Berlin, Germany
    Z Rheumatol 64:327-33. 2005
    ..Paediatric and adult rheumatologists should establish close cooperation and implement specific transition programs to meet the special health care needs of these patients...
  44. pmc Burden and cost of illness in patients with juvenile idiopathic arthritis
    K Minden
    Deutsches Rheuma ForschungsZentrum Berlin, Schumannstr 21 22, 10117 Berlin, Germany
    Ann Rheum Dis 63:836-42. 2004
    ..To estimate the cost of illness in an incidence based cohort of patients with juvenile idiopathic arthritis...
  45. ncbi request reprint [Comorbidity in rheumatoid arthritis of early onset. Effects on outcome parameters]
    G Westhoff
    Forschungsbereich Rheumatologie, Deutsches Rheuma Forschungszentrum Berlin DRFZ, Chariteplatz 1, 10117 Berlin, Deutschland
    Z Rheumatol 65:487-8, 490-4, 496. 2006
    ..The impact of comorbidity on measures of disease severity should be considered when used to compare outcome parameters of different RA samples...
  46. ncbi request reprint [Help status and help prospects of severely handicapped patients with rheumatoid arthritis]
    G Westhoff
    Deutsches Rheuma Forschungszentrum Berlin Schumannstr 21 22 10117 Berlin
    Z Rheumatol 60:28-40. 2001
    ....
  47. ncbi request reprint Health care provision in pediatric rheumatology in Germany--national rheumatologic database
    Kirsten Minden
    Epidemiology Unit, German Rheumatism Research Center Berlin
    J Rheumatol 29:622-8. 2002
    ..To describe the health care provision for children and adolescents with chronic arthritides in Germany in 1998...
  48. doi request reprint How well do patient reports reflect adverse drug reactions reported by rheumatologists? Agreement of physician- and patient-reported adverse events in patients with rheumatoid arthritis observed in the German biologics register
    Lotta Gäwert
    Epidemiology Unit, German Rheumatism Research Centre, Chariteplatz 1, D 10117 Berlin, Germany
    Rheumatology (Oxford) 50:152-60. 2011
    ..To analyse the validity of patient reports on adverse drug reactions (ADRs) compared with the reports given by the treating physician...
  49. doi request reprint Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS)
    Gisela Westhoff
    Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
    Rheumatology (Oxford) 48:650-7. 2009
    ..To assess the quality of health care for RA patients in the general population of Germany...
  50. doi request reprint Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents
    Anja Strangfeld
    Epidemiology Unit, German Rheumatism Research Center, Chariteplatz 1, 10117 Berlin, Germany
    JAMA 301:737-44. 2009
    ..The risk of bacterial infection is increased in patients treated with drugs that inhibit tumor necrosis factor alpha (TNF-alpha). Little is known about the reactivation of latent viral infections during treatment with TNF-alpha inhibitors...
  51. ncbi request reprint Long-term outcome in patients with juvenile idiopathic arthritis
    Kirsten Minden
    German Rheumatism Research Center, Berlin
    Arthritis Rheum 46:2392-401. 2002
    ..To describe the long-term outcome of juvenile idiopathic arthritis (JIA)...
  52. doi request reprint Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers
    Anja Strangfeld
    Epidemiology Unit, German Rheumatism Research Centre, a Leibniz Institute, Chariteplatz 1, D 10117 Berlin, Germany
    Rheumatology (Oxford) 50:146-51. 2011
    ..To evaluate this possible safety signal, a concerted analysis with the national biologics registers in the UK and Sweden was performed...
  53. doi request reprint Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
    Joachim Listing
    German Rheumatism Research Centre, Berlin, Germany
    Arthritis Rheum 58:667-77. 2008
    ..To determine the hazard risk of developing or worsening heart failure in rheumatoid arthritis (RA) patients treated with tumor necrosis factor alpha (TNFalpha) inhibitors...
  54. ncbi request reprint Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index
    Gisela Westhoff
    German Rheumatism Research Centre, Berlin, Germany
    Arthritis Rheum 56:3575-82. 2007
    ..To investigate the association between body mass index (BMI) and radiographic joint damage (using the Ratingen Score [RS]) in early rheumatoid arthritis (RA)...
  55. ncbi request reprint Current use of glucocorticoids in patients with rheumatoid arthritis in Germany
    Katja Thiele
    German Rheumatism Research Centre, Berlin
    Arthritis Rheum 53:740-7. 2005
    ..To describe the current use of glucocorticoids in German patients with rheumatoid arthritis (RA)...
  56. ncbi request reprint Infections in patients with rheumatoid arthritis treated with biologic agents
    Joachim Listing
    German Rheumatism Research Centre, Schumannstrasse 21 22, D 10117 Berlin, Germany
    Arthritis Rheum 52:3403-12. 2005
    ....
  57. ncbi request reprint Evaluation of the RABBIT Risk Score for serious infections
    A Zink
    Programmbereich Epidemiologie, Deutsches Rheuma ForschungsZentrum Berlin, ein Leibniz Institut, Berlin, Germany Klinik für Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin, Berlin, Germany
    Ann Rheum Dis 73:1673-6. 2014
    ..To evaluate the Rheumatoid Arthritis Observation of Biologic Therapy (RABBIT) Risk Score for serious infections in patients with rheumatoid arthritis (RA)...
  58. doi request reprint [Biomarkers in rheumatology. Biomarkers and imaging for the diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the ArthroMark network funded by the Federal Ministry of Education and Research]
    T Haupl
    Medizinische Klinik m S Rheumatologie und Klinische Immunologie, Charite Universitatsmedizin Berlin, Campus Mitte, Chariteplatz 1, 10117, Berlin, Deutschland
    Z Rheumatol 71:314-8. 2012
    ..To validate the markers for diagnostic application the network aims to expand gradually...
  59. doi request reprint Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997-2007: results from the National Database of the German Collaborative Arthritis Centres
    Stefanie Ziegler
    German Rheumatism Research Centre, Chariteplatz 1, Berlin, Germany
    Ann Rheum Dis 69:1803-8. 2010
    ..A study was undertaken to investigate to what extent this influenced daily rheumatological care and how this translates into clinical and patient-reported outcomes...
  60. ncbi request reprint Positioning of total knee arthroplasty with and without navigation support. A prospective, randomised study
    M Sparmann
    Orthopaedic Department, Immanuel Hospital, Free University of Berlin, Berlin, Germany
    J Bone Joint Surg Br 85:830-5. 2003
    ..0001). The use of a navigation system was therefore shown to improve the alignment of the implant...
  61. pmc Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
    Xenofon Baraliakos
    Rheumazentrum Ruhrgebiet, Herne, Germany
    Arthritis Res Ther 7:R439-44. 2005
    ..Discontinuation of long-term therapy with infliximab eventually led to relapse of disease activity in all patients but one...
  62. ncbi request reprint Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency
    Peter K Schädlich
    InForMed GmbH Outcomes Research and Health Economics, Bureau Itzehoe, Conrad Roentgen Strasse 58C, D 25524 Itzehoe, Ingolstadt, Germany
    Pharmacoeconomics 23:395-420. 2005
    ..e. rheumatological, care in Germany...
  63. ncbi request reprint Employment across chronic inflammatory rheumatic diseases and comparison with the general population
    Wilfried Mau
    Institute for Rehabilitation Medicine, Martin Luther University Halle Wittenberg, Halle, Germany
    J Rheumatol 32:721-8. 2005
    ..To compare labor force participation across chronic inflammatory rheumatic diseases in order to assess the influence of the disease, disease duration, sex, education, and labor market conditions on employment...
  64. ncbi request reprint Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs
    Peter K Schädlich
    InForMed GmbH Outcomes Research and Health Economics, Bureau Itzehoe, Conrad Roentgen Strasse 58C, D 25524 Itzehoe, Ingolstadt, Germany
    Pharmacoeconomics 23:377-93. 2005
    ..e. rheumatological, care in Germany...
  65. ncbi request reprint [Drug therapy in postmenopausal osteoporosis. An analysis of healty service delivery]
    Kurt Bestehorn
    Medizinische Forschung MSD Sharp and Dohme GmbH, Haar
    Z Arztl Fortbild Qualitatssich 96:699-704. 2002
    ....